Table of Contents

REVIEWS AND CONTEMPORARY UPDATES

• Why Human Subjects Research Protection Is Important

  Michael G. White

  Ochsner Journal March 2020, 20 (1) 16-33; DOI: https://doi.org/10.31486/toj.20.5012
• Vulnerability in Research: Basic Ethical Concepts and General Approach to Review

  Bruce G. Gordon

  Ochsner Journal March 2020, 20 (1) 34-38; DOI: https://doi.org/10.31486/toj.19.0079
• Research in Pregnant Subjects: Increasingly Important, but Challenging

  Joseph R. Biggio

  Ochsner Journal March 2020, 20 (1) 39-43; DOI: https://doi.org/10.31486/toj.19.0077
• Investigator Responsibilities in Clinical Research

  Amy K. Feehan and Julia Garcia-Diaz

  Ochsner Journal March 2020, 20 (1) 44-49; DOI: https://doi.org/10.31486/toj.19.0085
• Institutional Review Board Assessment—Balancing Efficiency and Quality

  Stephen J. Rosenfeld

  Ochsner Journal March 2020, 20 (1) 50-55; DOI: https://doi.org/10.31486/toj.19.0075
• How to Determine if a Project Is Human Subjects Research, a Quality Improvement Project, or Both

  Pat F. Bass and John W. Maloy

  Ochsner Journal March 2020, 20 (1) 56-61; DOI: https://doi.org/10.31486/toj.19.0087
• Revised Common Rule Changes to the Consent Process and Consent Form

  Leah L. LeCompte and Sylvia J. Young

  Ochsner Journal March 2020, 20 (1) 62-75; DOI: https://doi.org/10.31486/toj.19.0055
• Implementation of Common Rule Changes to the Informed Consent Form: A Research Staff and Institutional Review Board Collaboration

  Grace Gartel, Heather Scuderi and Christine Servay

  Ochsner Journal March 2020, 20 (1) 76-80; DOI: https://doi.org/10.31486/toj.19.0080
• Understanding Broad Consent

  John W. Maloy and Pat F. Bass

  Ochsner Journal March 2020, 20 (1) 81-86; DOI: https://doi.org/10.31486/toj.19.0088
• Exemptions and Limited Institutional Review Board Review: A Practical Look at the 2018 Common Rule Requirements for Exempt Research

  Amelia Walch-Patterson

  Ochsner Journal March 2020, 20 (1) 87-94; DOI: https://doi.org/10.31486/toj.19.0095
• Important Considerations for the Institutional Review Board When Granting Health Insurance Portability and Accountability Act Authorization Waivers

  Kelsey Williams and Paul Colomb

  Ochsner Journal March 2020, 20 (1) 95-97; DOI: https://doi.org/10.31486/toj.19.0083
• Precision Medicine and the Institutional Review Board: Ethics and the Genome

  Marc R. Matrana and Bob Campbell

  Ochsner Journal March 2020, 20 (1) 98-103; DOI: https://doi.org/10.31486/toj.19.0098
• Pitfalls and Safeguards in Industry-Funded Research

  Joseph L. Breault and Emily Knafl

  Ochsner Journal March 2020, 20 (1) 104-110; DOI: https://doi.org/10.31486/toj.19.0093